News from vanda pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 05, 2022, 16:10 ET Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2022. "We...

May 04, 2022, 16:30 ET Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare Conference

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the BofA Securities 2022 Healthcare Conference ...

Apr 28, 2022, 17:00 ET Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2022 on Thursday, May 5, 2022, after...

Feb 23, 2022, 16:01 ET Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended...

Feb 17, 2022, 18:00 ET Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2021 on Wednesday,...

Feb 04, 2022, 07:00 ET Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced results from its Phase III clinical study, VP-VLY-686-3303, evaluating the efficacy ...

Jan 14, 2022, 08:35 ET Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it has entered into a License Agreement (the License Agreement) with MSN...

Nov 10, 2021, 18:30 ET Vanda Pharmaceuticals Announces Participation at November 2021 Investor Conferences

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda management will participate at the following upcoming investor...

Nov 03, 2021, 16:01 ET Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2021....

Oct 27, 2021, 17:30 ET Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2021 on Wednesday, November 3, 2021,...

Oct 14, 2021, 16:30 ET Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021....

Sep 07, 2021, 20:30 ET Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma Virtual Conference

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the Citi 16th Annual BioPharma Virtual...

Aug 03, 2021, 07:00 ET Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that enrollment has closed in the ODYSSEY study comparing tradipitant and placebo...

Jul 28, 2021, 16:01 ET Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2021....

Jul 21, 2021, 16:30 ET Vanda Pharmaceuticals to Announce Second Quarter 2021 Financial Results on July 28, 2021

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2021 on Wednesday, July 28, 2021,...

May 12, 2021, 16:30 ET Vanda Pharmaceuticals Announces Participation at Upcoming 2021 Investor Conferences

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the following investor conferences:...

May 05, 2021, 16:01 ET Vanda Pharmaceuticals Reports First Quarter 2021 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2021....

Apr 20, 2021, 16:30 ET Vanda Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2021 on Wednesday, May 5, 2021, after ...

Feb 10, 2021, 16:01 ET Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended...

Feb 02, 2021, 16:30 ET Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 10, 2021

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2020 on Wednesday,...

Dec 01, 2020, 18:22 ET FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved HETLIOZ®...

Oct 28, 2020, 16:01 ET Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2020....

Oct 26, 2020, 16:01 ET Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational...

Oct 21, 2020, 16:45 ET Vanda Pharmaceuticals to Announce Third Quarter 2020 Financial Results on October 28, 2020

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2020 on Wednesday, October 28, 2020,...

Aug 31, 2020, 18:30 ET Vanda Pharmaceuticals Provides Update on Tradipitant Development Program

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its development program for tradipitant. Enrollment in Vanda's Phase...